Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)

<p>Abstract</p> <p>Background</p> <p>This study evaluated the measurement properties of a newly developed instrument – the Self-Management Profile for Type 2 Diabetes (SMP-T2D).</p> <p>Methods</p> <p>The 18-item SMP-T2D assesses 12 constructs: le...

Full description

Bibliographic Details
Main Authors: Peyrot Mark, Bushnell Donald M, Best Jennie H, Martin Mona L, Cameron Ann, Patrick Donald L
Format: Article
Language:English
Published: BMC 2012-10-01
Series:Health and Quality of Life Outcomes
Online Access:http://www.hqlo.com/content/10/1/125
id doaj-adcac33aa1d046a5b75658df3839bec5
record_format Article
spelling doaj-adcac33aa1d046a5b75658df3839bec52020-11-24T21:49:48ZengBMCHealth and Quality of Life Outcomes1477-75252012-10-0110112510.1186/1477-7525-10-125Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)Peyrot MarkBushnell Donald MBest Jennie HMartin Mona LCameron AnnPatrick Donald L<p>Abstract</p> <p>Background</p> <p>This study evaluated the measurement properties of a newly developed instrument – the Self-Management Profile for Type 2 Diabetes (SMP-T2D).</p> <p>Methods</p> <p>The 18-item SMP-T2D assesses 12 constructs: level and perceived ease of performance in five self-care domains (blood glucose monitoring, medication-taking, healthy eating, being physically active, and coping), and two global constructs (ease of weight management, confidence with ability to manage diabetes). Validation analyses were based on two studies involving 240 patients with T2D, Study 1 (Clinicaltrials.gov #NCT00637273) with SMP-T2D administration supplemented by SMP-T2D retest one week later, and Study 2 (Clinical trials.gov #NCT00877890) with SMP-T2D administration supplemented by 24-week SMP-T2D follow-up after medication change. Validation included clinical indicators and measures of patient reported quality of life, psychological well-being and treatment outcomes.</p> <p>Results</p> <p>All multi-item SMP-T2D measures showed acceptable internal consistency (alphas = 0.71 to 0.87); ten measures had test-retest reliability >0.75. Correlations among SMP-T2D measures and between SMP-T2D measures and validation measures, which were as hypothesized, provided evidence of convergent and discriminant validity. Scores for six SMP-T2D measures improved significantly during Study 2. Multiple regression analysis showed independent associations between change in SMP-T2D measures and change in trial outcomes from baseline to end-of-study.</p> <p>Conclusions</p> <p>Two studies provide preliminary evidence regarding the reliability, validity and responsiveness of the SMP-T2D. Further research on the utility of the instrument is needed.</p> http://www.hqlo.com/content/10/1/125
collection DOAJ
language English
format Article
sources DOAJ
author Peyrot Mark
Bushnell Donald M
Best Jennie H
Martin Mona L
Cameron Ann
Patrick Donald L
spellingShingle Peyrot Mark
Bushnell Donald M
Best Jennie H
Martin Mona L
Cameron Ann
Patrick Donald L
Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
Health and Quality of Life Outcomes
author_facet Peyrot Mark
Bushnell Donald M
Best Jennie H
Martin Mona L
Cameron Ann
Patrick Donald L
author_sort Peyrot Mark
title Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
title_short Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
title_full Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
title_fullStr Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
title_full_unstemmed Development and validation of the self-management profile for type 2 diabetes (SMP-T2D)
title_sort development and validation of the self-management profile for type 2 diabetes (smp-t2d)
publisher BMC
series Health and Quality of Life Outcomes
issn 1477-7525
publishDate 2012-10-01
description <p>Abstract</p> <p>Background</p> <p>This study evaluated the measurement properties of a newly developed instrument – the Self-Management Profile for Type 2 Diabetes (SMP-T2D).</p> <p>Methods</p> <p>The 18-item SMP-T2D assesses 12 constructs: level and perceived ease of performance in five self-care domains (blood glucose monitoring, medication-taking, healthy eating, being physically active, and coping), and two global constructs (ease of weight management, confidence with ability to manage diabetes). Validation analyses were based on two studies involving 240 patients with T2D, Study 1 (Clinicaltrials.gov #NCT00637273) with SMP-T2D administration supplemented by SMP-T2D retest one week later, and Study 2 (Clinical trials.gov #NCT00877890) with SMP-T2D administration supplemented by 24-week SMP-T2D follow-up after medication change. Validation included clinical indicators and measures of patient reported quality of life, psychological well-being and treatment outcomes.</p> <p>Results</p> <p>All multi-item SMP-T2D measures showed acceptable internal consistency (alphas = 0.71 to 0.87); ten measures had test-retest reliability >0.75. Correlations among SMP-T2D measures and between SMP-T2D measures and validation measures, which were as hypothesized, provided evidence of convergent and discriminant validity. Scores for six SMP-T2D measures improved significantly during Study 2. Multiple regression analysis showed independent associations between change in SMP-T2D measures and change in trial outcomes from baseline to end-of-study.</p> <p>Conclusions</p> <p>Two studies provide preliminary evidence regarding the reliability, validity and responsiveness of the SMP-T2D. Further research on the utility of the instrument is needed.</p>
url http://www.hqlo.com/content/10/1/125
work_keys_str_mv AT peyrotmark developmentandvalidationoftheselfmanagementprofilefortype2diabetessmpt2d
AT bushnelldonaldm developmentandvalidationoftheselfmanagementprofilefortype2diabetessmpt2d
AT bestjennieh developmentandvalidationoftheselfmanagementprofilefortype2diabetessmpt2d
AT martinmonal developmentandvalidationoftheselfmanagementprofilefortype2diabetessmpt2d
AT cameronann developmentandvalidationoftheselfmanagementprofilefortype2diabetessmpt2d
AT patrickdonaldl developmentandvalidationoftheselfmanagementprofilefortype2diabetessmpt2d
_version_ 1725887362363293696